Business ❯ Healthcare ❯ Pharmaceuticals

Manufacturing

Eli Lilly Radioligand Therapy Company Investments Biologics Manufacturing Facilities Nutraceuticals Takeovers Active Pharmaceutical Ingredients Anlon Healthcare Ltd. SteriPort and SVP Sterile Liquid Products Peptide Manufacturing Investment Rubicon Research Syringe Production Cold Chain Storage Facility Development AstraZeneca CSL Limited Food-Grade Iron Phosphate Product Distribution Excipients Cell Therapy Cell and Gene Therapy Expansion Novo Nordisk Sterile Pharmaceuticals

Novo Nordisk Invests €432 Million to Expand Athlone Plant for Oral GLP-1 Tablets

The upgrade positions the site to supply markets outside the U.S. ahead of a possible EMA decision on the Wegovy pill.

Novartis to Build 46,000‑Square‑Foot Radioligand Therapy Plant in Denton, Texas

Johnson & Johnson to Build $1 Billion Cell Therapy Plant in Pennsylvania

Eli Lilly Chooses Pennsylvania for $3.5 Billion Plant to Produce Weight-Loss Injectables

Eli Lilly Picks Lehigh Valley for $3.5 Billion Plant to Make Next-Gen Weight-Loss Drugs

BD Invests $110 Million to Launch Neopak Syringe Production in Nebraska

AstraZeneca Invests $2 Billion to Expand Maryland Biologics and Build New Clinical Site

Novartis Opens Carlsbad Radioligand Therapy Plant as U.S. Buildout Accelerates

Cencora Commits Over $1 Billion to U.S. Drug Distribution Buildout Through 2030

Eli Lilly Unveils $3 Billion Netherlands Plant to Scale Production of Oral Weight‑Loss Pill